The forecasted data indicates a gradual decline in pneumonia mortality among males in the US from 2024 to 2028, decreasing annually from 23.86 thousand deaths in 2024 to 23.66 thousand in 2028. In 2023, pneumonia mortality stood at 23.91 thousand. The year-on-year decline from 2024 to 2028 is consistent at approximately 0.21%, reflecting a steady downward trend. The compound annual growth rate (CAGR) over the last five years projects an average annual decrease in mortality rate.
Future trends to watch for include advancements in medical treatments and vaccinations, impacts of public health initiatives, potential shifts in demographics, and environmental factors that may influence pneumonia incidence and mortality rates.
